INHIBITEX, INC. (INHX) [Rocket]

In millions, except per share items	Sep-30-11	Jun-30-11	Mar-31-11	Dec-31-10	Sep-30-10	Jun-30-10	Mar-31-10	Dec-31-09
	10-Q	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K
Revenue:
License fees and milestones	1.0	0.0			0.0	0.0
Collaborative research and development.	0.3	0.3			0.3	0.3
Total revenue	1.3	0.3	0.3	0.3	0.3	0.3	1.0	0.3
Total revenue growth	339.1%	0.0%	-71.2%	0.0%	-92.7%	-92.2%	-71.4%	-63.5%
Operating expense:
Research and development	5.7	4.6			4.7	4.9
General and administrative	0.9	1.0			0.9	1.0
Total operating expense	6.6	5.6			5.6	5.9
Loss from operations.	-5.3	-5.3			-5.3	-5.6
Operating margin	-419.9%	-1835.5%			-1840.2%	-1943.4%
Other income (loss), net	0.0	0.0			0.0	0.0
Interest income, net	0.0	0.0			0.0	0.0
Net loss	-5.3	-5.3			-5.3	-5.6

Basic and diluted net loss per share	($0.07)	($0.07)			($0.08)	($0.09)

Weighted average shares used to compute basic and diluted net loss per share	78.1	75.1			62.2	61.8